Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03015129
Title A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial carcinoma

Therapies

Durvalumab

Durvalumab + Tremelimumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.